8 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA)Geographic Atrophy, eye disorder, macular degeneration, retinal degeneration, retinal disorderActive, not recruitingPhase 32026-10-06NCT06510816
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)Metaplasia, Neovascularization, Pathologic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, age-related macular degeneration, choroidal neovascularization, eye disorder, macular degeneration, optic choroid disorder, retinal degeneration, retinal disorder, uveal disorder, wet macular degenerationRecruitingPhase 2 / Phase 32026-10-02NCT07440225
Extension Study for the Port Delivery System With Ranibizumab (Portal)Neovascular Age-Related Macular DegenerationRecruitingPhase 32026-09-28NCT03683251
Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDRProliferative Diabetic Retinopathy (PDR)RecruitingPhase 32026-09-18NCT06790784
ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD)eye disorder, macular degeneration, retinal degeneration, retinal disorderActive, not recruitingPhase 32026-09-17NCT06373731
An Observational Study of the Progression of Intermediate Age-Related Macular Degenerationage-related macular degeneration, eye disorder, macular degeneration, retinal degeneration, retinal disorderActive, not recruitingNot stated2026-09-16NCT05300724
Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMDNeovascular Age-related Macular DegenerationActive, not recruitingPhase 32026-07-07NCT05904028
4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degenerationeye disorder, macular degeneration, retinal degeneration, retinal disorder, wet macular degenerationActive, not recruitingPhase 32026-06-01NCT06864988